EDCTP side event at UNGA79 Science Summit
Investing in clinical research in Africa to develop local solutions against the global challenge of Antimicrobial Resistance (AMR)
26 September 2024 11:00-13:00 EDT | 17:00-19:00 CET (Virtual) - Link to the virtual session here.
*Participation is free but registration is required to attend the virtual sessions. Instructions below.
As part of the Science Summit during the 79th United Nations General Assembly (SSUNGA79), EDCTP will organise a side event that aims to illustrate the value of investing in clinical research and development of accessible and affordable antibiotics, diagnostics, and vaccines for addressing unmet medical needs in Africa through a global partnership such as EDCTP.
The objectives of the session will be to:
- Promote awareness about EDCTP and its role and contribution towards attaining the SDGs.
- Highlight the role of R&D in tackling AMR and showcase practical examples of how the EDCTP programmes have supported clinical research on AMR.
- Discuss the priority elements for mitigating AMR and achieving the SDGs, including adopting a One Heath approach, ensuring equitable access to antimicrobials, recognising prevention as the cornerstone of response, and safeguarding adequate, sustainable and predictable financing for antibiotic, diagnostics, and vaccine development.
The side event will count with the participation of:
- Yewande Alimi, AMR and One Health Unit Lead, Africa CDC.
- David Barros, Vice President and Head of Global Health Medicines R&D Unit, GlaxoSmithKline.
- Julia Anna Bielicki, Penta Foundation Board Member and Reader at City St. George's, University of London.
- Joseph Fokam, Head of Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB).
- Samuel Kariuki, Director, Eastern Africa, DNDi.
- Michael Makanga, Executive Director at Global Health EDCTP3.
- Irene Norstedt, Director, People Directorate, Directorate-General for Research and Innovation, European Commission.
- Francine Ntoumi, Founder, President and Executive Director of the Congolese Foundation for Medical Research (FCRM).
- Marcel Tanner, EDCTP High Representative.
- Marleen Temmerman, Director Women's Health, Faculty of Health Sciences, Aga Khan University.
- Jutta Reinhard-Rupp, Head of the Global Health Institute, Merck KGaA.
- Lara Pandya, Communications & Strategic Partnerships at Global Health EDCTP3 (convenor).
We are happy to announce that Michael Makanga, Executive Director of Global Health EDCTP3, will also be participating virtually in two other plenaries:
The Role of Africa Science Leadership: Advancing Sustainable Development in Africa on 23 September, 10:00-12:30 EDT / 16:00-18:30 CEST. Link to the session here.
- One Health Plenary, Panel 3: Financing for Development on 25 September, 12:30-13:15 EDT / 18:30-19:15 CEST. Link to the session here.
Visit the SSUNGA79 website to access the agenda of the event.
*Participation is free but registration is mandatory to attend the virtual sessions. Once registered, you can join sessions by clicking at the circular checkbox icon next to each sessions on the event platform. Please ensure you select the sessions you wish to attend, as failure to do so will prevent access to the live stream.
